BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Policy

  Acticor Biotech: Progress in Discussions with EU and US Regulatory Agencies

  Acticor Biotech, a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, is discussing with the FDA and the EMA its development program for the acute ischemic stroke indication.

  May 30, 2023

   · 

  5 min read
• At 5.6% CAGR, Retinal Imaging Devices Market to hit $3Bn, Globally, by 2028 | The Insight Partners

  The Insight Partners published latest research study on “Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Device Type (Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography)

  May 30, 2023

   · 

  6 min read
• Business

  Fluent BioSciences Partners with Genspace to Unleash the Power of PIPseq™: Empowering Community Scientists to Transform Genomic Research

  Fluent BioSciences, a life science tools company, delivering single-cell technology to laboratories across the United States and abroad, collaborates with Genspace by sponsoring a community science workshop in Brooklyn, NY.

  May 30, 2023

   · 

  2 min read
• Human Microbiome Market Size Worth $2.92Bn by 2028 at 22.2% CAGR Led by Probiotics Products (24.71% Market Share in 2021) Global Analysis by The Insight Partners

  The Insight Partners published latest research study on “Human Microbiome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements)

  May 30, 2023

   · 

  11 min read
• $12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners

  The Insight Partners published latest research study on “Influenza Vaccines Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028

  May 30, 2023

   · 

  8 min read